Axogen

IPO

Peripheral Nerve Repair & Surgery Technologies

Public · Alachua, United States · Founded 2002 · $192.3M raised

Headquarters
Alachua, Florida
Employees
501–1000
Founded
2002
Business Model
B2B
Total Funding
$192.3M
Last Round
$124.0M Growth EquityJan 2026
Rounds
5
Type
Public

About

Axogen, Inc. is a medical technology company founded in 2002 and headquartered in Alachua, Florida. It is the only company solely focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen's product portfolio includes the Avance Nerve Graft and Axoguard Nerve Connector and Protector devices, with clinical data showing sensory and motor recovery in 87% of patients. The company is publicly traded on Nasdaq (AXGN).

Summary

Axogen is a Healthcare company based in Alachua, United States, founded in 2002. It has raised $192.3M in total across 5 rounds, most recently a $124.0M Growth Equity round in Jan 2026. Investors include Accuitive Medical Ventures, Cardinal Partners and De Novo Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Growth EquityGrowth EquityJan 2026
$124.0M

Sign up to see all 5 rounds

Series B through Growth Equity — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Axogen on Indexed.vc
<a href="https://indexed.vc/companies/axogen"><img src="https://indexed.vc/api/badge/company/axogen" alt="Axogen on Indexed.vc" width="260" height="76" /></a>